Analyst Update: 3M Stock's Price Target Revised with 20% Upside Potential

Friday, 19 April 2024, 15:18
The latest analyst update on 3M highlights a revised price target and ongoing debate. JPMorgan's new $110 target implies a near-20% upside despite the spinoff of its healthcare business. Wall Street remains cautious due to potential dividend cuts and ongoing legal challenges, impacting investor sentiment.
https://store.livarava.com/b9b273bd-fe60-11ee-a6bf-63e1980711b2.jpg
Analyst Update: 3M Stock's Price Target Revised with 20% Upside Potential

Why the price target changed

Despite seemingly lower price target, reflects spin off of 3M's healthcare business now as Solventum. Analyst's revised target after spinoff signifies upgraded outlook.

Analyst update impact

Analyst's upbeat target contrasts other firms' cautious stance. Concerns over dividend cuts and legal settlements weigh on stock's outlook.

Investment decision

Considering operational challenges and ongoing legal issues, cautious approach advised.

Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe